Floatz logo

INSULIN GLARGINE (SANOFI)

Diabetic Ketoacidosis

Changhua Christian Hospitalprotein_peptidePhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diabetic Ketoacidosis cohort.

Asset / SponsorPhaseRating
Pioglitazone
Emory University
D

Same molecule, other indications

INSULIN GLARGINE (SANOFI) is also rated in:

Diabetes Mellitus, Type 2Dormant
BB
Indicative ·
66 / 100
View asset →
HyperglycemiaDormant
B
Indicative ·
63 / 100
View asset →
Non-alcoholic Fatty Liver DiseaseDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →